Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

InMed Pharmaceuticals (INM) Return on Assets (2022 - 2025)

InMed Pharmaceuticals (INM) has 4 years of Return on Assets data on record, last reported at 0.62% in Q4 2025.

  • For Q4 2025, Return on Assets rose 21.0% year-over-year to 0.62%; the TTM value through Dec 2025 reached 0.62%, up 21.0%, while the annual FY2025 figure was 0.6%, 0.0% changed from the prior year.
  • Return on Assets reached 0.62% in Q4 2025 per INM's latest filing, down from 0.57% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.42% in Q1 2024 and bottomed at 1.4% in Q3 2022.
  • Average Return on Assets over 4 years is 0.77%, with a median of 0.62% recorded in 2025.
  • Peak YoY movement for Return on Assets: soared 84bps in 2023, then tumbled -51bps in 2025.
  • A 4-year view of Return on Assets shows it stood at 1.08% in 2022, then surged by 55bps to 0.49% in 2023, then tumbled by -72bps to 0.83% in 2024, then grew by 25bps to 0.62% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.62% in Q4 2025, 0.57% in Q3 2025, and 0.66% in Q2 2025.